Article
Enhanced doxorubicin production by Streptomyces peucetius using a combination of classical strain mutation and medium optimization.
Preparative biochemistry & biotechnology - 1 Jan 2018
Wang Xiaoru, Tian Xiaorong, Wu Yuanjie, Shen Xiaofang, Yang Songbai, Chen Shaoxin
Abstract excerpt
Doxorubicin (DXR), which is produced by Streptomyces peucetius, is an important anthracycline-type antibiotic used for the treatment of various cancers. However, due to the low DXR productivity of wild-type S. peucetius, it is difficult to produce DXR by one-step fermentation. In this study, a DXR-resistance screening method was developed to screen for DXR high-producing mutants. Then, S. peucetius SIPI-11 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
